|
Prevalence of eNOS genotype in hypertensives and normotensives with cardiovascular damage |
||||
| G894T |
Normotensives n.67 |
% |
Hypertensives n. 127 |
% |
|
|
||||
| GG |
5 |
7.5 |
33 |
26.0* |
| GT+TT |
14 |
20.9 |
52 |
40.9# |
|
|
||||
|
|
||||
| T786C |
Normotensives n.38 |
% |
Hypertensives n.107 |
% |
|
|
||||
| TT |
2 |
5.3 |
17 |
15.9 |
| TC+CC |
14 |
36.8 |
57 |
53.2 |
|
|
||||
|
|
||||
| Introne4 |
Normotensives n. 31 |
% |
Hypertensives n. 119 |
% |
|
|
||||
| bb |
10 |
32.3 |
62 |
52.1 |
| ab+aa |
3 |
9.7 |
21 |
17.6 § |
|
* p < 0,001 vs normotensives # p < 0,007 vs normotensives § p < 0,05 vs normotensives | ||||
Colomba et al. Immunity & Ageing 2008 5:4 doi:10.1186/1742-4933-5-4 |
||||